CUU LONG PHARMACEUTICAL |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 27,300 VND | 0.00% |
|
+5.00% | +9.20% |
| Sales 2022 | 1,016B 39.61M 54.85M | Sales 2023 | 1,144B 44.61M 61.77M | Capitalization | 1,826B 71.22M 98.61M |
|---|---|---|---|---|---|
| Net income 2022 | 112B 4.35M 6.03M | Net income 2023 | 61.72B 2.41M 3.33M | EV / Sales 2022 | 2.11 x |
| Net Debt 2022 | 352B 13.73M 19.01M | Net Debt 2023 | 512B 19.98M 27.67M | EV / Sales 2023 | 2.04 x |
| P/E ratio 2022 |
15.4
x | P/E ratio 2023 |
29.6
x | Employees | 930 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 41.95% |
More Fundamentals
* Assessed data
More news
| 1 week | +5.00% | ||
| Current month | +13.28% | ||
| 1 month | +13.28% | ||
| 3 months | +10.30% | ||
| 6 months | +21.60% | ||
| Current year | +9.20% |
1 week
25 300.00
27 450.00
1 month
23 250.0029 300.00
Current year
23 200.0029 300.00
1 year
21 700.0029 300.00
3 years
21 700.0053 600.00
5 years
16 000.0053 600.00
10 years
7 428.5753 600.00
| Managers | Title | Age | Since |
|---|---|---|---|
Minh Hoai Thi Vu
CEO | Chief Executive Officer | - | 21-05-17 |
Sang Van Nguyen
CHM | Chairman | 48 | 14-12-18 |
Khanh Quoc Trinh
DFI | Director of Finance/CFO | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 53 | - | |
Sang Van Nguyen
CHM | Chairman | 48 | 14-12-18 |
| Director/Board Member | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-26 | 27,300 | 0.00% | 210,100 |
| 24-04-25 | 27,300 | +0.18% | 296,300 |
| 24-04-24 | 27,250 | +4.81% | 250,000 |
| 24-04-23 | 26,000 | +0.39% | 330,600 |
| 24-04-22 | 25,900 | -0.38% | 436,600 |
End-of-day quote Ho Chi Minh S.E., April 25, 2024
More quotes
Cuu Long Pharmaceutical Joint Stock Corporation (Pharimexco) is a Vietnam-based company engaged in the pharmaceutical industry. The Company manufactures, markets and distributes pharmaceutical drugs and capsules, as well as medical equipment and supplies. It is also involved in the manufacture and trading of functional food, cosmetic products, chemicals and other materials for pharmaceutical production. Other activities include the manufacture of specialized packagings for drugs and medical products, as well as the cultivation of traditional herbs.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| +9.20% | 78.71M | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
- Stock Market
- Equities
- DCL Stock
